GDR genedrive plc

LSE · GB · Healthcare · Diagnostics & Research · genedriveplc.com

1.175GBP-2.08%Mkt Cap: 24.20M $P/E: —3d ago

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The co…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc Common Stock

$242.11BUSDP/E 35.5

DHR

Danaher Corporation Common Stock

$150.48BUSDP/E 38.2

NTRA

Natera, Inc. - Common Stock

Agilent Technologies, Inc. Common Stock

$47.30BUSDP/E 33.1

IQV

IQVIA Holdings, Inc. Common Stock

$42.50BUSDP/E 32.2

WAT

Waters Corporation Common Stock

$41.75BUSDP/E 107.4

ILMN

Illumina, Inc. - Common Stock

$41.23BUSDP/E 50.8

IDXX

IDEXX Laboratories, Inc. - Common Stock

$40.89BUSDP/E 36.4

MTD

Mettler-Toledo International, Inc. Common Stock

$29.78BUSDP/E 34.0

DGX

Quest Diagnostics Incorporated Common Stock

$25.75BUSDP/E 25.0

Labcorp Holdings Inc. Common Stock

$25.02BUSDP/E 25.5

Guardant Health, Inc. - Common Stock

$23.86BUSD

RVTY

Revvity, Inc. Common Stock

$16.91BUSDP/E 72.5

MEDP

Medpace Holdings, Inc. - Common Stock

$16.73BUSDP/E 35.2

ERF

Eurofins Scientific SE

$13.92BUSDP/E 26.0

CRL

Charles River Laboratories International, Inc. Common Stock

$13.85BUSD

ICLR

ICON plc - Ordinary Shares

Qiagen N.V. Common Shares

$9.24BUSDP/E 22.7

Key Statistics

Company

Market Cap24.20M USD

Enterprise Value15.66M USD

Revenue (TTM)1.51M USD

Gross Profit-4.28M USD

Net Income (TTM)-6.71M USD

Revenue/Share0.0020 GBP

Last Price1.175 GBP

Fiscal Year EndJun 2025

MR QuarterDec 2025

Employees43

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)0.01

PEG—

EV/EBITDA-2.27

EV/Revenue10.40

P/S16.07

P/B—

EPS (TTM)-0.01

EPS (Forward)2.10

52W Range

0.210072% of range1.550

52W High1.550 GBP

52W Low0.2100 GBP

Profitability

Gross Margin-283.99%

Oper. Margin-459.47%

EBITDA Margin0.00%

Profit Margin-684.69%

ROE-363.77%

ROA-185.83%

Growth

Revenue Growth62.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.60M USD

CapEx (TTM)29.50K USD

FCF Margin-173.52%

FCF Yield-10.80%

Net Debt144.93K USD

Net Debt/EBITDA-0.02

Balance Sheet

Debt/Equity0.00

Current Ratio0.99

Quick Ratio0.78

Book Value/Sh0.00 GBP

Cash/Share0.00 GBP

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBP

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.61B

Float560.86M

Insiders44.96%

Institutions1.24%

Technical

SMA 501.230 (-4.5%)

SMA 2001.111 (+5.8%)

Beta1.00

S&P 52W Chg14.58%

Avg Vol (30d)4.45M

Avg Vol (10d)3.57M

Technical Indicators

RSI (14)41.8

MACD-0.0196

MACD Signal-0.0103

MACD Hist.-0.0093

BB Upper1.367 GBP

BB Middle1.241 GBP

BB Lower1.115 GBP

BB Width20.29%

ATR (14)0.1090 GBP

Vol Ratio (20d)0.59x